Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol BCL6 contributors: mct/pgu - updated : 10-04-2016
HGNC name B-cell CLL/lymphoma 6
HGNC id 1001
ASSOCIATED DISORDERS
corresponding disease(s) FL3B
Other morbid association(s)
TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
tumoral   translocation    
in B cell lymphomas, translocations t(3;14), t(3;13),t(2;3),t(3;22),t(3;4),t(3;11)and others
tumoral fusion      
in primary diffuse large B-cell lymphomas of the central nervous system with poor prognosis
tumoral fusion      
fused with histone H4 in t(3;6)(q27;p21), in non-Hodgkin's lymphoma
tumoral   translocation    
with HSPCA and GAPD in primary diffuse large B-cell lymphomas of the central nervous system
tumoral   translocation    
alternative translocation breakpoint cluster region associated with follicular lymphoma grade 3B
tumoral somatic mutation      
somatic point mutations in non-Hodgkin lymphomas (NHL)
tumoral     --other  
expressed in systemic anaplastic large cell lymphomas
Susceptibility
Variant & Polymorphism
Candidate gene
Marker
Therapy target
SystemTypeDisorderPubmed
cancerhemopathy 
combination modalities targeting the multiple oncogenic activities of BCL6 and the anti-apoptotic function of BCL2 may represent a rational approach for the treatment of a subset of DLBCL
cancerhemopathy 
dual targeting of oncogenic tyrosine kinases and BCL6-dependent feedback represents a novel strategy to eradicate drug-resistant and leukaemia-initiating subclones in tyrosine-kinase-driven leukaemia
ANIMAL & CELL MODELS